Industry Focus

T-Mobile and Sprint have faced opposition from federal regulators over their planned $26.5 billion merger. Speculation that the deal may not be approved has led Sprint to send a statement to the Department of Justice saying that if the deal gets denied, it may not be able to survive. Fool Contributor Daniel Kline joins Shannon Jones to break that down and to take some time to sort out the streaming video industry.

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

Thanks to Molekule for supporting Industry Focus.  Get $75 off your first order at http://www.molekule.com code fool75.

On this episode of Industry Focus: Financials, Fool.com contributor Matt Frankel, CFP sits down with Gunther Bright, Executive Vice President, Merchant Services U.S. for American Express to discuss how Amex has evolved in recent years. After, Frankel and host Jason Moser discuss a trio of earnings from Bank of America (NYSE: BAC), Morgan Stanley (NYSE: MS), and Travelers (NYSE: TRV) and answer a listener question about investing in wealth management firms. And, as always, we close out the show with two stocks we’re keeping our eye on now.

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

Thanks to Molekule for supporting Industry Focus.  Get $75 off your first order at http://www.molekule.com code fool75.

On this episode of Industry Focus: Financials, Fool.com contributor Matt Frankel, CFP sits down with Gunther Bright, Executive Vice President, Merchant Services U.S. for American Express to discuss how Amex has evolved in recent years. After, Frankel and host Jason Moser discuss a trio of earnings from Bank of America (NYSE: BAC), Morgan Stanley (NYSE: MS), and Travelers (NYSE: TRV) and answer a listener question about investing in wealth management firms. And, as always, we close out the show with two stocks we’re keeping our eye on now.

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

Thanks to Molekule for supporting Industry Focus.  Get $75 off your first order at http://www.molekule.com code fool75.

Last Friday, Chevron announced a $33 billion acquisition of Anadarko Petroleum, one of the biggest energy mergers in years. Motley Fool Contributor Matt Dilallo and Industry Focus host Nick Sciple break down the deal, take a look at Kinder Morgan’s most recent earnings report, and preview upcoming earnings from some of their favorite oil companies.

Stocks Mentioned: CVX, APC, KMI, HES, XOM, COP

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

Last Friday, Chevron announced a $33 billion acquisition of Anadarko Petroleum, one of the biggest energy mergers in years. Motley Fool Contributor Matt Dilallo and Industry Focus host Nick Sciple break down the deal, take a look at Kinder Morgan’s most recent earnings report, and preview upcoming earnings from some of their favorite oil companies.

Stocks Mentioned: CVX, APC, KMI, HES, XOM, COP

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

Marijuana stocks OrganiGram and Aphria reported quarterly earnings this week - here's what you should know. Also, Abbott locks horns with DexCom in diabetes and what's next for Bristol-Myers' now that its Celgene acquisition is official.

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

Marijuana stocks OrganiGram and Aphria reported quarterly earnings this week - here's what you should know. Also, Abbott locks horns with DexCom in diabetes and what's next for Bristol-Myers' now that its Celgene acquisition is official.

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

We're tapping deep into childhood nostalgia on this show -- kids birthday party staple Chuck E. Cheese is planning to go public in 2019 and the details on Disney+ are finally available. One of these developments should have investors happy, the other one... not so much.

Stocks: DIS, CEC

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

We're tapping deep into childhood nostalgia on this show -- kids birthday party staple Chuck E. Cheese is planning to go public in 2019 and the details on Disney+ are finally available. One of these developments should have investors happy, the other one... not so much.

Stocks: DIS, CEC

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

In this episode, we look at the bank earnings (so far) and learn about person-to-person payment platform Zelle. In the latest edition of our Between Two Fools interview series, Fool.com contributor Matt Frankel, CFP sits down with Lou Anne Alexander, Group President of Payments for Early Warning, the company behind person-to-person payment platform Zelle. Later, Frankel and Industry Focus: Financials host Jason Moser discuss earnings from JPMorgan Chase (NYSE: JPM), and both tell listeners about the stocks on their radar this week.

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter